share_log

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga Real-time News ·  Jan 18, 2023 16:32

Gainers

  • Bellerophon Therapeutics (NASDAQ:BLPH) shares increased by 18.4% to $2.9 during Wednesday's after-market session. This security traded at a volume of 416.2K shares come close, making up 40.3% of its average volume over the last 100 days. The company's market cap stands at $27.6 million.
  • NanoVibronix (NASDAQ:NAOV) shares rose 12.32% to $0.36. The market value of their outstanding shares is at $11.8 million.
  • Nymox Pharmaceutical (NASDAQ:NYMX) shares moved upwards by 10.34% to $0.53. The market value of their outstanding shares is at $47.9 million.
  • Infinity Pharmaceuticals (NASDAQ:INFI) shares increased by 7.69% to $0.75. The market value of their outstanding shares is at $66.6 million.
  • Kiromic BioPharma (NASDAQ:KRBP) shares rose 7.31% to $0.22. The market value of their outstanding shares is at $4.0 million.
  • Tivic Health Systems (NASDAQ:TIVC) shares rose 7.0% to $0.77. The company's market cap stands at $7.4 million.

Losers

  • Lyell Immunopharma (NASDAQ:LYEL) stock decreased by 6.1% to $2.81 during Wednesday's after-market session. The market value of their outstanding shares is at $699.7 million.
  • Ontrak (NASDAQ:OTRKP) stock fell 6.11% to $1.23. Today's trading volume for this security ended up closing at 51.0K shares, which is 282.2 percent of its average volume over the last 100 days.
  • Biofrontera (NASDAQ:BFRI) stock decreased by 5.26% to $0.9. The company's market cap stands at $24.0 million.
  • Seelos Therapeutics (NASDAQ:SEEL) stock declined by 5.0% to $0.93. The company's market cap stands at $99.7 million.
  • Concert Pharma (NASDAQ:CNCE) shares declined by 4.93% to $6.56. The market value of their outstanding shares is at $314.4 million.
  • Zynerba Pharmaceuticals (NASDAQ:ZYNE) stock decreased by 4.92% to $0.58. The market value of their outstanding shares is at $27.2 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment